Track topics on Twitter Track topics that are important to you
Dublin, June 02, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/sg4g9k/bioburden_testing) has announced the addition of the "Bioburden Testing Market by Product , Test, Application & End User - Forecast to 2019" report to their offering.
The bioburden testing market is expected to reach $565.6 Million by 2019 from $354.4 Million in 2014, growing at a CAGR of 9.8% from 2014 to 2019
On the basis of products, the microbial limit testing market is segmented into consumables and instruments. The consumables market is further segmented into culture media and reagents & kits and other consumables. The instruments market is further segmented into PCR, microscopes, automated microbial identification systems, and other instruments.
On the basis of test types, the global bioburden market is segmented into aerobic count, anaerobic count, fungi/mold count, and spores count. On the basis of applications, the market is segmented into raw material testing, medical devices testing, in-process testing, sterilization validation testing, and equipment cleaning validation.
Based on end users, the market is segmented into pharmaceutical and biotechnology companies, medical devices manufacturers, contract manufacturing organizations (CMOs), manufacturers of food & beverage and agricultural products, and microbial testing laboratories.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Bioburden Testing Market, By Product
8 Bioburden Testing Market, By Test Type
9 Bioburden Testing Market, By Application
10 Bioburden Testing Market, By End User
11 Geographic Analysis
12 Competitive Landscape
13 Company Profiles
- ATS Labs, Inc.
- Becton, Dickinson, and Company
- Charles River Laboratories International, Inc.
- Merck & Co., Inc.
- Nelson Laboratories, Inc.
- North American Science Associates, Inc. (NAMSA)
- Pacific Biolabs
- SGS S.A.
- Sigma-Aldrich Corporation
- WUXI Pharmatech (Cayman), Inc.
For more information visit http://www.researchandmarkets.com/research/sg4g9k/bioburden_testing
CONTACT: Research and Markets Laura Wood, Senior Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: BiotechnologyNEXT ARTICLE
Polymerase Chain Reaction (PCR)
PCR (Polymerase Chain Reaction) uses the ability of DNA polymerase (enzymes that create DNA molecules by assembling nucleotides, the building blocks of DNA. These enzymes are essential to DNA replication and usually work in pairs to create two ident...
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...